Morgan Stanley Maintains Equal-Weight on Endava, Lowers Price Target to $4

Benzinga Newsdesk www.benzinga.com Neutral 76.4%

Neg 0% Neu 76.4% Pos 0%

Morgan Stanley analyst James Faucette maintains Endava (NYSE:DAVA) with a Equal-Weight and lowers the price target from $8 to $4.